No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
INFU240816P10000
- 1.50
- 0.000.00%
15min DelayClose Jul 23 15:59 ET
0.00High0.00Low
1.50Open1.50Pre Close0 Volume0 Open Interest10.00Strike Price0.00Turnover0.01%IV-22.30%PremiumAug 16, 2024Expiry Date3.05Intrinsic Value100Multiplier24DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-1.0000Delta0.0000Gamma2.28Leverage Ratio0.0000Theta0.0000Rho-2.28Eff Leverage0.0000Vega
Intraday
- 5D
- Daily
News
Why Is Minerva Advisors Bullish on InfuSystem Holdings, Inc. (INFU) Right Now?
Sidoti Events, LLC's Virtual June Small-Cap Conference
InfuSystem to Present at Sidoti Small Cap Conference on June 12, 2024
InfuSystems(INFU.US) Director Buys US$28,520 in Common Stock
InfuSystems(INFU.US) Director Buys US$29,485.53 in Common Stock
InfuSystems(INFU.US) Officer Buys US$6,387.5 in Common Stock
Comments
Gainers:
• $GTY Technology(GTYH.US$ +118.1% (entered into a definitive agreement to be acquired by GI Partners )
• $Finch Therapeutics(FNCH.US$ +68.33% (announces removal of FDA clinical hold on CP101 IND)
• $Zymeworks(ZYME.US$ +42.34% (confirms receipt of non-binding proposal from All Blue Falcons for $10.50 per share in cash)
• $Hub Group(HUBG.US$ +16.3% (earnings reports)
• $Lantheus(LNTH.US$ +14.2% (earnings reports)
• $Mohawk Industries(MHK.US$ +13.7% (e...
• $GTY Technology(GTYH.US$ +118.1% (entered into a definitive agreement to be acquired by GI Partners )
• $Finch Therapeutics(FNCH.US$ +68.33% (announces removal of FDA clinical hold on CP101 IND)
• $Zymeworks(ZYME.US$ +42.34% (confirms receipt of non-binding proposal from All Blue Falcons for $10.50 per share in cash)
• $Hub Group(HUBG.US$ +16.3% (earnings reports)
• $Lantheus(LNTH.US$ +14.2% (earnings reports)
• $Mohawk Industries(MHK.US$ +13.7% (e...
18
Read more